Investors pushed Nippon Care Supply to ¥4,375 at the close on 30 October, capping a flat month but a strong 90 day run. The fresh Q2 2027 release lands into that optimism with a clear headline. Earnings power is solid, yet the stock already trades on a rich 27.8x trailing P/E, well above Japan healthcare peers.
The short term story is simple: profitability has improved on a trailing basis and the market has been willing to pay up. The harder question is whether that premium price, and a discounted cash flow estimate below the market level, leaves much room for long term upside.
Like the earnings power at Nippon Care Supply but uneasy about paying a premium 27.8x trailing P/E for it? Filter for similar profitability profiles without the rich valuation tag using our 14 high quality undervalued stocks.
Q2 2027 Earnings Summary
- Revenue (Q2 2027 vs Q2 2026): ¥9,592 million vs. ¥8,589 million (around 11.7% higher year on year)
- Net Income (Excl. Extra Items, Q2 2027 vs Q2 2026): ¥686 million vs. ¥582 million (around 17.9% higher year on year)
- Basic EPS (Q2 2027 vs Q2 2026): ¥44.14 per share vs. ¥37.46 per share (around 17.8% higher year on year)
- Trailing 12 Month Net Profit Margin (Q2 2027 vs Q2 2026): 6.7% vs. 6.2% (modest margin improvement over the year)
Earnings tell part of the story, but investors who care about what they are paying for usually want to see how profits translate into hard cash. Nippon Care Supply's recent report gives that profit snapshot; however, on cash flows alone the stock could be a modest 9% overvalued.
Nippon Care Supply earnings keep defensive story intact
The bullish angle on Nippon Care Supply leans on steady eldercare demand, and the latest numbers do not fight that story. Revenue of ¥9,592 million and net income of ¥686 million are both higher year on year, with basic EPS also moving up. A trailing net margin at 6.7%, compared with 6.2% a year earlier, points to slightly better efficiency. For a welfare equipment and services provider tied to daily care needs, that mix of higher sales and firmer profitability fits a gradual, resilience focused thesis.
Profit gains leave valuation worries as the key risk
Bears often focus on thin margins and competitive pressure in welfare rentals. The current set of results softens that concern rather than intensifying it. Nippon Care Supply shows higher net income and EPS alongside a modest margin improvement, which does not hint at immediate strain in the underlying business. Recent share performance, including a roughly flat 30 day move after a stronger 90 day run, suggests expectations have not run wildly ahead of the fundamentals. That tilts the near term risk debate more toward what investors pay than whether the business model is cracking.
With a premium 27.8x P/E on Nippon Care Supply and a share price above the DCF estimate, the key question is whether the balance sheet quietly justifies that confidence. Check the full liquidity, debt and cash coverage picture inside the financial health analysis of Nippon Care Supply stock.Hunt Balance Sheets Before Crowds
Nippon Care Supply has reported firmer profitability and its valuation is now the main focus of debate. The real opportunity is finding stocks that could be low debt before investors fully recognize their balance sheet strength.
- Company 1 - 35% below our estimate - compounds hiring and local services spending as clients adopt AI driven matching and automation products.
- Company 2 - 45% below our estimate - expands an AI native security platform as more customers shift budgets toward subscription based protection and managed services.
- Company 3 - 18% below our estimate - grows maintenance and modernization work as an enlarged salesforce targets dense clusters of installed equipment for new contracts.
Three companies from the same screener. Open every one of the 22 solid balance sheet companies →
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com